Biotech entity
Every one of those 1 sits in a single category, pharma. Nautilus Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Thermo Fisher Scientific appears in 1 tracked Biotech story from February 27, 2026.
Last mentioned: 1d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Nautilus Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Thermo Fisher Scientific appears in 1 tracked Biotech story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Thermo Fisher Scientific. Shared-story counts are live from our verified record — not editorial picks.
Seer (NASDAQ: SEER) reported quarterly earnings that exceeded analyst expectations by $0.03 per share, signaling resilience in the life sciences tools sector. The results highlight growing adoption of the company's Proteograph Product Suite as researchers increasingly prioritize high-resolution proteomics in drug discovery.
Thermo Fisher Scientific is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
